Evaluation of the humoral response during ocrelizumab therapy in multiple sclerosis - an observational study.

Rychter J, Podlecka-Piętowska A, Sujkowska K, Sierdziński J, Zakrzewska-Pniewska B, Nojszewska M

Neurol Neurochir Pol. 2026 Jul 21. PMID: 42478450. Abstract